Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Feb. 8, 2026

Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb appeared on the CBS television program "Face the Nation with Margaret Brennan" on February 8, 2026, to provide expert analysis on the current state of American public health and pharmaceutical innovation. During the broadcast, Gottlieb shared his insights into the evolving landscape of medical regulation and healthcare delivery, drawing from his unique perspective as a former high-ranking government official who now serves on the corporate boards of Pfizer and United Health Care. The discussion focused on addressing the nation's most pressing medical challenges and the logistical hurdles facing the contemporary healthcare system. As a prominent voice in the medical community, Dr. Gottlieb utilized his platform to evaluate the intersection of private sector development and public sector oversight. His dual roles in the private pharmaceutical industry and insurance sectors allow for a multifaceted view of how new treatments reach the public. Throughout the interview, he addressed the necessary balance between rapid innovation and the rigorous safety standards required by federal regulators, a topic that remains at the forefront of national political and health policy debates. The interview serves as a critical update for stakeholders in the healthcare industry, providing a glimpse into the strategic thinking of a leader who influences both medical manufacturing and insurance reimbursement policies. By appearing on a major national news program, Gottlieb signaled ongoing efforts to maintain transparency between health organizations and the American public. The conversation underscored the importance of bipartisan cooperation in achieving sustainable healthcare reform and the continued need for vigilance regarding emerging global health threats in 2026.